MSR1 (Macrophage Scavenger Receptor-A, aka CD204), has been found elevated in GB as compared to other cancers; its expression is associated with glioma progression [32], and increased levels at the tissue level have been associated with poorer survival outcomes in several cancers, and the serum data in the present analysis support this. This evidence concerns the gene MSR1 and central nervous system cancer.